# US 2012/0253453 A1 · Durable high strength polymer composite suitable for implant and articles produced therefrom

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2012/0253453 A1
- Document ID: US20120253453A1
- Status: Published application
- Kind: A1
- Application number: 13/078,774
- Filed: 2011-04-01
- Published: 2012-10-04
- Earliest claimed: 2011-04-01
- Assignees: Gore Enterprise Holdings, Inc.
- Inventors: William C. Bruchman; Paul D. Gassler; Cody L. Hartman; Peter J. Walsh; Charles F. White
- Web page: https://patentgrep.com/patent/US20120253453A1

## CPC

- A61L 27/48: with macromolecular fillers
- A61F 2/2415: {Manufacturing methods}
- A61F 2/2418: {Scaffolds therefor, e.g. support stents}
- A61L 27/507: {for artificial blood vessels (apparatus for applying cells on a blood vessel prosthesis A61F2/062)}
- A61F 2/2412: {with soft flexible valve members, e.g. tissue valves shaped like natural valves}
- A61F 2/2472: {Devices for testing}
- A61F 2/2475: {Venous valves}
- A61F 2210/0076: multilayered, e.g. laminated structures
- A61F 2220/005: using adhesives
- A61F 2230/00: Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F 2230/0006: circular
- A61F 2230/0013: Horseshoe-shaped, e.g. crescent-shaped, C-shaped, U-shaped
- A61F 2230/0054: V-shaped
- A61L 27/025: {Other specific inorganic materials not covered by A61L27/04 - A61L27/12}
- A61L 27/40: Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
- A61L 2430/20: for reconstruction of the heart, e.g. heart valves
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- A61F: FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS (dental prosthetics A61C)

## Abstract

A thin, biocompatible, high-strength, composite material is disclosed that is suitable for use in various implanted configurations. In one aspect, the composite material maintains flexibility in high-cycle flexural applications, making it particularly applicable to high-flex implants such as heart pacing lead or heart valve leaflet. The composite material includes a porous expanded fluoropolymer membrane and an elastomer, wherein the elastomer fills substantially all of the pores of the porous expanded fluoropolymer, and the composite material comprising less than about 80% fluoropolymer by weight.

## Claims

### Claim 1

An implantable article for regulating blood flow direction in a human patient, said implantable article comprising:
a leaflet comprising a composite material having at least one fluoropolymer layer having a plurality of pores and an elastomer present in substantially all of the pores of the at least one fluoropolymer layer, the composite material comprising less than about 80% fluoropolymer by weight.

### Claim 2 (depends on 1)

The implantable article as set forth in claim 1, wherein the composite material comprising less than about 70% fluoropolymer by weight.

### Claim 3 (depends on 1)

The implantable article as set forth in claim 1, wherein the composite material comprising less than about 60% fluoropolymer by weight.

### Claim 4 (depends on 1)

The implantable article as set forth in claim 1, wherein the composite material comprising less than about 50% fluoropolymer by weight.

### Claim 5 (depends on 1)

The implantable article as set forth in claim 1, wherein the composite material further includes a layer of the elastomer.

### Claim 6 (depends on 5)

The implantable article as set forth in claim 5, wherein the elastomer is a fluoroelastomer.

### Claim 7 (depends on 6)

The implantable article as set forth in claim 6, wherein the elastomer is a TFE/PMVE copolymer.

### Claim 8 (depends on 7)

The implantable article as set forth in claim 7, wherein the copolymer consists essentially of between about 40 and 80 weight percent perfluoromethyl vinyl ether and complementally 60 and 20 weight percent tetrafluoroethylene.

### Claim 9 (depends on 5)

The implantable article as set forth in claim 5, wherein the fluoropolymer is PTFE.

### Claim 10 (depends on 9)

The implantable article as set forth in claim 9, wherein the PTFE is ePTFE.

### Claim 11 (depends on 10)

The implantable article as set forth in claim 10, wherein the at least one fluoropolymer layer has a matrix tensile strength in at least one direction greater than about 96 MPa.

### Claim 12 (depends on 1)

The implantable article as set forth in claim 1, wherein the elastomer is a fluoroelastomer.

### Claim 13 (depends on 12)

The implantable article as set forth in claim 12, wherein the elastomer is a TFE/PMVE copolymer.

### Claim 14 (depends on 13)

The implantable article as set forth in claim 13, wherein the copolymer consists essentially of between about 40 and 80 weight percent perfluoromethyl vinyl ether and complementally about 60 and 20 weight percent tetrafluoroethylene.

### Claim 15 (depends on 1)

The implantable article as set forth in claim 1, wherein the fluoropolymer is PTFE.

### Claim 16 (depends on 15)

The implantable article as set forth in claim 15, wherein the PTFE is ePTFE.

### Claim 17 (depends on 16)

The implantable article as set forth in claim 16, wherein the at least one fluoropolymer layer has a matrix tensile strength in at least one direction greater than about 96 MPa.

### Claim 18 (depends on 1)

The implantable article as set forth in claim 1, wherein the leaflet has a thickness of less than about 350 μm.

### Claim 19 (depends on 1)

The implantable article as set forth in claim 1, wherein the leaflet has a thickness of less than about 300 μm

### Claim 20 (depends on 1)

The implantable article as set forth in claim 1, wherein the leaflet has a thickness of less than about 200 μm.

### Claim 21 (depends on 1)

The implantable article as set forth in claim 1, wherein the leaflet has a thickness of less than about 100 μm.

### Claim 22 (depends on 1)

The implantable article as set forth in claim 1, wherein the leaflet has a thickness of less than about 50 μm.

### Claim 23 (depends on 1)

The implantable article as set forth in claim 1, wherein the leaflet has a thickness of less than about 25 μm.

### Claim 24 (depends on 1)

The implantable article as set forth in claim 1, wherein the EOA across the implantable article for regulating blood flow direction is maintained within about 10% after about 40 million cycles.

### Claim 25 (depends on 1)

The implantable article as set forth in claim 1, wherein a regurgitant fraction across the implantable article for regulating blood flow direction is maintained below about 15% after about 40 million cycles.

### Claim 26 (depends on 1)

The implantable article as set forth in claim 1, wherein the leaflet is devoid of edge delamination or hole formation after about 40 million cycles.

### Claim 27 (depends on 1)

A method of forming the composite material of the implantable article of claim 1, said method comprising the steps of:
dissolving an elastomer in a solvent suitable to create a solution to substantially fill the pores of the membrane;
substantially fill the pores of the membrane; and
allowing the solvent to evaporate so that the elastomer remains in substantially all of the pores of the membrane.

### Claim 28 (depends on 1)

A method of forming the composite material of the implantable article of claim 1, said method comprising the step of delivering the elastomer via a dispersion to substantially fill the pores of the at least one fluoropolymer layer.

### Claim 29 (depends on 1)

A method of forming the composite material of the implantable article of claim 1, said method comprising the step of bringing the at least one fluoropolymer layer into contact with a sheet of the elastomer under conditions of heat and/or pressure that allow elastomer to substantially fill the pores of the at least one fluoropolymer layer.

### Claim 30 (depends on 1)

A method of forming the composite material of the implantable article of claim 1, said method comprising the step of polymerizing the elastomer within the pores of the at least one fluoropolymer layer.

### Claim 31 (depends on 10)

The implantable article as set forth in claim 10, wherein the composite material comprising less than about 50% fluoropolymer by weight.

### Claim 32

An implantable article for regulating blood flow direction in a human patient, said implantable article comprising:
a support structure;
a leaflet supported on the support structure and movable between open and closed positions to regulate blood flow through the implantable article; and
a cushion member located between at least a portion of the support structure and at least a portion of the leaflet, wherein the cushion member is formed from a composite material with at least one fluoropolymer layer having a plurality of pores and an elastomer present in substantially all of the pores.

### Claim 33 (depends on 32)

The implantable article as set forth in claim 32, wherein the cushion member includes expanded fluoropolymer.

### Claim 34 (depends on 32)

The implantable article as set forth in claim 32, wherein the cushion member is formed as a fiber.

### Claim 35 (depends on 32)

The implantable article as set forth in claim 32, wherein the cushion member is formed as a sheet.

### Claim 36 (depends on 32)

The implantable article as set forth in claim 32, wherein the cushion member is formed as a tube.

### Claim 37 (depends on 34)

The implantable article as set forth in claim 34, wherein the cushion member is wrapped generally helically about the at least a portion of the support structure to provide a cushion between the at least a portion of the support structure and the leaflet.

### Claim 38 (depends on 32)

The implantable article as set forth in claim 32, wherein the support structure includes a longitudinally extending post about which a portion of the leaflet is wrapped to secure the leaflet to the support structure.

### Claim 39 (depends on 38)

The implantable article as set forth in claim 38, wherein the cushion member is formed from porous ePTFE, wherein pores contain elastomer.

### Claim 40 (depends on 39)

The implantable article as set forth in claim 39, wherein the cushion member is formed as a fiber.

### Claim 41 (depends on 40)

The implantable article as set forth in claim 40, wherein the fiber is wrapped generally helically about the post to provide a cushion between the post and the portion of the leaflet wrapped about the post.

### Claim 42 (depends on 40)

The implantable article as set forth in claim 40, wherein the fiber is formed from a sheet of ePTFE having a plurality of pores and an elastomer present in substantially all of the pores.

### Claim 43

An implantable article for regulating blood flow direction in a human patient, said implantable article comprising:
a generally annular shaped support structure, the support structure having a first end and an opposite second end, the first end having a longitudinally extending post;
a sheet of leaflet material extending along an outer periphery of the support structure and forming a first leaflet and a second leaflet each extending along opposite sides of the post; and
a cushion member is coupled to the post and provides a cushion between the post and the leaflets.

### Claim 44 (depends on 43)

The implantable article as set forth in claim 43, wherein the cushion member is a fiber formed from a sheet of ePTFE having a plurality of pores and an elastomer present in substantially all of the pores.

### Claim 45

An implantable article for regulating blood flow direction in a human patient, said implantable article comprising:
a leaflet comprising a composite material having at least one fluoropolymer layer having a plurality of pores and an elastomer substantially filling the pores of the at least one fluoropolymer layer, the composite material comprising less than about 80% fluoropolymer by weight.

### Claim 46

An implantable heart valve for regulating blood flow direction in a human patient, said heart valve comprising:
a leaflet cyclable between a first configuration for allowing blood flow through the heart valve and a second configuration for substantially preventing blood flow through the heart valve, the leaflet comprising a composite material having at least one fluoropolymer layer having a plurality of pores and an elastomer present in substantially all of the pores of the at least one fluoropolymer layer,
wherein the composite material has less than about 55% fluoropolymer by weight and a thickness of less than 120 μm.

### Claim 47 (depends on 46)

The implantable heart valve as set forth in claim 46, wherein the EOA across the implantable article for regulating blood flow direction is maintained within about 10% after about 40 million cycles.

### Claim 48 (depends on 46)

The implantable heart valve as set forth in claim 46, wherein a regurgitant fraction across the implantable article for regulating blood flow direction is maintained below about 15% after about 40 million cycles.

### Claim 49 (depends on 46)

The implantable heart valve as set forth in claim 46, wherein the leaflet is devoid of edge delamination or hole formation after about 40 million cycles.
